Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study.

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73580790" target="_blank" >RIV/61989592:15110/17:73580790 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.2147/NDT.S122483" target="_blank" >http://dx.doi.org/10.2147/NDT.S122483</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/NDT.S122483" target="_blank" >10.2147/NDT.S122483</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study.

Popis výsledku v původním jazyce

The quality of life was significantly higher in employed patients and individuals with higher hope, self-directedness (SD), and persistence (PS). The quality of life was lower among patients with higher number of psychiatric hospitalizations, those with higher severity of the disorder, and individuals who were taking higher doses of antipsychotics. Patients with more pronounced symptoms of depression, anxiety, and social anxiety had a lower quality of life. Finally, the quality of life was lower among individuals with higher harm avoidance (HA) and self-stigmatization (ISMI).

Název v anglickém jazyce

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study.

Popis výsledku anglicky

The quality of life was significantly higher in employed patients and individuals with higher hope, self-directedness (SD), and persistence (PS). The quality of life was lower among patients with higher number of psychiatric hospitalizations, those with higher severity of the disorder, and individuals who were taking higher doses of antipsychotics. Patients with more pronounced symptoms of depression, anxiety, and social anxiety had a lower quality of life. Finally, the quality of life was lower among individuals with higher harm avoidance (HA) and self-stigmatization (ISMI).

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30215 - Psychiatry

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Neuropsychiatric Disease and Treatment

ISSN

1176-6328

e-ISSN

—

Svazek periodika

23

Číslo periodika v rámci svazku

13

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

10

Strana od-do

567-576

Kód UT WoS článku

000394686700001

EID výsledku v databázi Scopus

—